This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07531/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07531/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07531/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07531/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07531/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07531
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07531 n14:DB07531
dcterms:title
4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE
adms:identifier
n6:DB07531 n7:C62 n8:4714713 n10:5828196 n13:99444002
n3:IUPAC-Name
n4:271B4D76-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4D7C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4D7B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4D78-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4D79-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4D7A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4D74-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4D75-363D-11E5-9242-09173F13E4C5 n4:271B4D72-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4D73-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4D82-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4D83-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4D7D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4D7E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4D80-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4D7F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4D81-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4D88-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4D8A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4D8B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4D87-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4D86-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4D89-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4D77-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4D84-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4D85-363D-11E5-9242-09173F13E4C5